Antibacterial oral rinse formulation for preventing coronary artery disease

An antibacterial oral rinse formulation for inhibiting transient bacteremia associated with causing inflammatory diseases or inflammatory processes associated with diseases as a result of oral hygiene activities in an individual, consisting essentially of the following compounds from tea tree oil:

• 75% v/v terpinen-4-ol, 2% v/v 1,8-cineole, 2% v/v alpha-terpineol, 5% v/v beta-pinene, 2% v/v p-cymene, 2% v/v limonene, 2% v/v aromadendrene, and 2% v/v terpinolene, in which the total amount of the compounds from tea tree oil in the formulation is 3% v/v;
• the following compounds from green tea extract in equal amounts:
• gallocatechin, epigallocatechin, epicatechin, and epigallocatechin gallate, in which the total amount of the compounds in the green tea extract in the formulation is 20% v/v;
• Menthas arvensis, in which the total amount of the Menthas arvensis in the formulation is 1 % v/v;
• chlorophyll;
• calcium sorbate;
• polysorbate 80;
• glycerin;
• sodium biphosphate;
• and water, wherein the antibacterial oral rinse formulation is contacted with an individual's oral cavity for a period of time immediately prior to said oral hygiene activity.